Staff Members - Benha University
Comparison of cabergoline versus calcium infusion in ovarian hyperstimulation syndrome prevention: A randomized clinical trial q
Middle East Fertility Society Journa • 2018
Publication Information
Authors
Mohamed Anwar Elnory
Ashraf Nassif Mahmoud Elmantwe
Keywords
Ovarian hyperstimulation syndrome (OHSS)
Calcium infusion
Cabergoline
Intracytoplasmic sperm injection (ICSI)
Polycystic ovarian syndrome (PCOS
Journal
Middle East Fertility Society Journa
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Aim: To compare effectiveness of calcium infusion (CI) versus oral cabergoline (OC) in lowering the incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high risk women undergoing
in vitro-fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles.
Patients and methods: This trial was conducted at Benha University Hospital and Hawaa specialized infertility center, including 230 women undergoing ICSI, 115 women received intravenous Calcium gluconate
starting at ovum pick up (OPU) day and 115 women received OC 0.5 mg starting at the day of OPU outcomes were the overall incidence of OHSS as well as its type and severity, in addition to others pregnancy
outcomes data.
Results: The occurrence of overall OHSS was significantly lower in calcium infusion group (CIG) than in
oral cabergoline group (OCG) [16/115 (13.9%) in CIG versus 32/115 (27.8%)] in OCG with difference in
proportion percentage point (D pp) = 13.9% , at 95%CI of 3.38% to 24.10% (P = 0.009) and absolute
risk reduction (ARR) in overall OHSS incidence = 13.9% at 95%CI of 3.38–24.10 and relative risk (RR) =
0.5 at 95% CI of 0.29–0.85 (p = 0.012) and relative risk reduction (RRR) = 50% and number need to treatment (NNT) (Benefit) = 7.18 at 95% CI of 4.12 (Benefit) to 28.05 (Benefit)]. Also the incidence of Moderate
OHSS was significantly lower in CIG than OCG [2/115 (1.7 %) vs 10/115 (8.6%), p = 0.01] as well as RR of
severe OHSS with CI to OC = 0.25 at 95%CI of 0.02–2.20 and RRR of severe OHSS with CI to OC was 75% as
it occurred in 4 cases (3.4%) in OCG versus one case (0.8%) in CIG, where this reduction is of great clinical
significant despite it does not reach statistical significance (P = 0.17), at NNT (Benefit) = 38.33 at 95% CI of
87.292 (Harm) to 1 to 15.716 (Benefit) .Other pregnancy outcomes didn’t show any statistically significant differences.
Conclusion: Calcium infusion is more effective than oral cabergoline intake from OPU day in the reduction
of OHSS overall incidence as well as its severity with comparable pregnancy outcomes.
in vitro-fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles.
Patients and methods: This trial was conducted at Benha University Hospital and Hawaa specialized infertility center, including 230 women undergoing ICSI, 115 women received intravenous Calcium gluconate
starting at ovum pick up (OPU) day and 115 women received OC 0.5 mg starting at the day of OPU outcomes were the overall incidence of OHSS as well as its type and severity, in addition to others pregnancy
outcomes data.
Results: The occurrence of overall OHSS was significantly lower in calcium infusion group (CIG) than in
oral cabergoline group (OCG) [16/115 (13.9%) in CIG versus 32/115 (27.8%)] in OCG with difference in
proportion percentage point (D pp) = 13.9% , at 95%CI of 3.38% to 24.10% (P = 0.009) and absolute
risk reduction (ARR) in overall OHSS incidence = 13.9% at 95%CI of 3.38–24.10 and relative risk (RR) =
0.5 at 95% CI of 0.29–0.85 (p = 0.012) and relative risk reduction (RRR) = 50% and number need to treatment (NNT) (Benefit) = 7.18 at 95% CI of 4.12 (Benefit) to 28.05 (Benefit)]. Also the incidence of Moderate
OHSS was significantly lower in CIG than OCG [2/115 (1.7 %) vs 10/115 (8.6%), p = 0.01] as well as RR of
severe OHSS with CI to OC = 0.25 at 95%CI of 0.02–2.20 and RRR of severe OHSS with CI to OC was 75% as
it occurred in 4 cases (3.4%) in OCG versus one case (0.8%) in CIG, where this reduction is of great clinical
significant despite it does not reach statistical significance (P = 0.17), at NNT (Benefit) = 38.33 at 95% CI of
87.292 (Harm) to 1 to 15.716 (Benefit) .Other pregnancy outcomes didn’t show any statistically significant differences.
Conclusion: Calcium infusion is more effective than oral cabergoline intake from OPU day in the reduction
of OHSS overall incidence as well as its severity with comparable pregnancy outcomes.